• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>AstraZeneca PLC ADR

AstraZeneca PLC ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin

    Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin

  2. Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets

    Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets

  3. Assay Depot Partners with Kansas City Area Life Science Institute to Create World’s First Academic Research Exchange

    Assay Depot Partners with Kansas City Area Life Science Institute to Create World’s First Academic Research Exchange

  4. FDA Panel Votes Against Accelerated Approval of AstraZeneca Ovarian Cancer Drug

    FDA Panel Votes Against Accelerated Approval of AstraZeneca Ovarian Cancer Drug

  5. The Friday Five

    This week: The Fed discloses an end to the taper, eurozone concerns resurface, and a cupcake firm crumbles.

  6. U.K. ready to toughen up takeover rules

    U.K. ready to toughen up takeover rules

  7. EUROPE MARKETS: Alcatel Higher In Europe, But Orange Shares Sour

    EUROPE MARKETS: Alcatel Higher In Europe, But Orange Shares Sour

  8. UPDATE: Alcatel higher in Europe, but Orange shares sour

    UPDATE: Alcatel higher in Europe, but Orange shares sour

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.